Summary of COVID-19 vitamin K studies
Studies
Meta Analysis
Hide extended summaries
Analysis of 7,766 adults in France, showing higher intakes of vitamin C, folate, vitamin K, dietary fibre, and fruit and vegetables associated with lower seropositivity.
Nov 2021, BMC Medicine, https://link.springer.com/article/10.1186/s12916-021-02168-1/fulltext.html, https://c19p.org/deschasauxtanguyvk
RCT 40 hospitalized COVID-19 patients showing vitamin K2 supplementation was well-tolerated and reduced dp-ucMGP levels, reflecting improved vitamin K status, but did not affect desmosine, a marker of elastic fiber degradation. The study was not powered to assess effects on clinical outcomes. Authors suggest that the dose may have been insufficient to fully correct the vitamin K deficiency seen in COVID-19, and that higher doses might be required to achieve potential protective effects against inflammation or lung damage.
Jun 2024, J. Clinical Medicine, https://www.mdpi.com/2077-0383/13/12/3476, https://c19p.org/visser
1. Deschasaux-Tanguy et al., Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort
7,766 patient vitamin K prophylaxis study: 14% fewer cases (p=0.04).Analysis of 7,766 adults in France, showing higher intakes of vitamin C, folate, vitamin K, dietary fibre, and fruit and vegetables associated with lower seropositivity.
Nov 2021, BMC Medicine, https://link.springer.com/article/10.1186/s12916-021-02168-1/fulltext.html, https://c19p.org/deschasauxtanguyvk
2. Visser et al., Vitamin K2 Supplementation in Hospitalised COVID-19 Patients: A Randomised Controlled Trial
40 patient vitamin K late treatment RCT: 200% higher mortality (p=1), 200% higher ICU admission (p=0.6), and 17% shorter hospitalization (p=0.52).RCT 40 hospitalized COVID-19 patients showing vitamin K2 supplementation was well-tolerated and reduced dp-ucMGP levels, reflecting improved vitamin K status, but did not affect desmosine, a marker of elastic fiber degradation. The study was not powered to assess effects on clinical outcomes. Authors suggest that the dose may have been insufficient to fully correct the vitamin K deficiency seen in COVID-19, and that higher doses might be required to achieve potential protective effects against inflammation or lung damage.
Jun 2024, J. Clinical Medicine, https://www.mdpi.com/2077-0383/13/12/3476, https://c19p.org/visser
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.